from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0386/-

LFCtreatmentdescriptionclass of inhibitor

-0.316

Amikacinug/mL Amikacintranslation

-0.465

Cap5-10ug/mL Capreomycintranslation

-0.097

Rox10-50 ug/mL Roxithromycintranslation

-0.509

SM2-5 ug/mL Streptomycintranslation

-0.261

Tet5-10 ug/mL Tetracyclinetranslation

0.305

Rif0.2-5ug/mL Rifampicintranscription

-0.659

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.619

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.178

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.529

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.713

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.541

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.902

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.568

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.446

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.126

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.669

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.391

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.405

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.711

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.673

KCN5-20 ug/mL Potassium cyaniderespiration

-0.798

NaN30.2-2 mM Sodium aziderespiration

-0.992

Nigericin50 uM Nigericinrespiration

1.011

TRC10-150 ug/mL Triclosanrespiration

-0.501

TRZ10-25 ug/mL Thioridazinerespiration

0.464

Valinomycin0.5-10 uM Valinomycinrespiration

-2.213

ZnSO42 mM ZnSO4respiration

-0.834

menadione6-10 ug/mL Menadionerespiration

-0.023

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.425

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.154

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.122

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.136

NRP_1Non-replicating persistence stage 1dosRassociated

-0.812

Amp0.2mg/mL AmpicillincellWall

-0.225

Cephalexin20-100 ug/mL CephalexincellWall

0.171

Cerulenin0.32-5 ug/mL CerulenincellWall

0.197

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.135

EMB10-20 ug/mL EthambutolcellWall

-0.375

Eta12-40 ug/mL EthionamidecellWall

-0.794

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.058

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.475

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.386

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.501

BZA0.12 mg/mL BenzamidearomaticAmides

0.688

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.140

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.130

H2O24 mM hydrogen peroxideDNAdamaging

-0.160

Levo10 ug/mL LevofloxacinDNAdamaging

0.127

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.540

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.294

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.391

UVUV-irradiationDNAdamaging

1.162

ARP41-4 ug/mL Antitubercular compound ARP4?

0.646

Antimycin12.5-50 ug/mL Antimycin A?

-0.858

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.251

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.411

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.537

PA8240.2-2 ug/mL PA-824?

0.829

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.873

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.752

Verapamil50 uM Verapamil?

-1.273

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.053

methoxatin10-20 ug/mL Methoxatin?